Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Awards Supporting Cutting-Edge Technologies for…

U.S. National Institutes of Health·United States of America

Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)

Closes 6/18/2026$500k – $2MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Center for Advancing Translational Sciences (NCATS) invites applications for the Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) Notice of Funding Opportunity (NOFO) to foster investigator-initiated development of highly innovative technologies to address barriers, limitations, or bottlenecks in translational science particularly for therapeutic development. This program will support the early-stage proof of concept, high-risk and potentially high-reward studies for feasibility and exploratory technology development, which can transform or significantly improve the efficiency of therapeutic development to achieve NCATS ultimate goals - more treatments to all people more quickly. The research proposed should be for the development of technology that can break new ground or extend present technology toward new directions or novel applications. With this initiative, we expect to support the development and/or prototyping of new technologies that will lead to improved efficiency in the therapeutic development pipeline. • The program aims to support innovative technologies for translational science. • The focus is on early-stage proof of concept and high-risk, high-reward studies. • The goal is to improve the efficiency of therapeutic development. • Eligible applicants include various types of organizations, such as nonprofits, institutions of higher education, and small businesses. • The application deadline is June 18, 2026.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
5/11/2023
Closes
6/18/2026

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-25-157

Budget estimate

$500,000 – $2,000,000

The budget amount for this grant is not specified, but based on the focus on innovative technologies for translational science, it is likely that the award amount will be substantial, potentially in the range of $500,000 to $2 million, considering the goals of supporting early-stage proof of concept and high-risk, high-reward studies. The actual budget amount will depend on the specific proposals and the review process.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 76%

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/25/2021

U.S. National Institutes of Health·United States of America

76% match

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

Closes 11/16/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

Closes 10/19/2027Opened 12/11/2024

U.S. National Institutes of Health·United States of America

75% match

NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

Closes 12/1/2030Opened 2/27/2026

U.S. National Institutes of Health·United States of America

75% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

75% match

Clinical and Translational Science Award (UM1 Clinical Trial Optional)

Closes 9/28/2027Opened 9/3/2024

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award

Closes 2/15/2027Opened 7/20/2026

U.S. National Institutes of Health·United States of America

75% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science

Closes 1/24/2027Opened 7/20/2026

U.S. National Institutes of Health·United States of America

74% match

Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)

Closes 9/28/2027Opened 12/12/2024

U.S. National Institutes of Health·United States of America

74% match

Clinical and Translational Science Award

Closes 1/24/2027Opened 7/20/2026

U.S. National Institutes of Health·United States of America

74% match

Limited Competition: Research Education Program for the Clinical and Translational Science Awards Program

Closes 1/24/2027Opened 7/20/2026

U.S. National Institutes of Health·United States of America

73% match

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Closes 8/11/2027Opened 12/30/2024

U.S. National Institutes of Health·United States of America

73% match

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Closes 7/20/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

73% match

Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)

Closes 5/28/2027Opened 12/9/2024

U.S. National Institutes of Health·United States of America

73% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

73% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

73% match

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Closes 1/7/2028Opened 3/25/2021

U.S. National Institutes of Health·United States of America

73% match

Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)

Closes 9/28/2027Opened 12/10/2024

U.S. National Institutes of Health·United States of America

73% match

Limited Competition: Institutional Mentored Research Career Development Program for the Clinical and Translational Science Awards Program

Closes 2/11/2027Opened 7/20/2026

U.S. National Institutes of Health·United States of America

72% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

72% match

Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant for the Clinical and Translational Science Awards Program

Closes 1/24/2027Opened 7/20/2026

U.S. National Institutes of Health·United States of America

72% match

Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)

Closes 9/28/2027Opened 12/12/2024

U.S. National Institutes of Health·United States of America

72% match

NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)

Closes 11/1/2026Opened 5/6/2026

U.S. National Institutes of Health·United States of America

72% match

Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)

Closes 4/8/2029Opened 6/11/2025